Proliferative reactive gliosis is compatible with glial metabolic support and neuronal function

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Vázquez Chona, Félix R ^a   Swan, Alex ^a   Ferrell, W Drew ^a   Jiang, Li ^a   Baehr, Wolfgang ^a   Chien, Wei Ming ^b   Fero, Matthew ^b   Marc, Robert E ^a   Levine, Edward M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cdkn1b; Gfap; Intermediate filaments; M ller glia; Neuronal degeneration; P27kip1; Reactive gliosis; Retinal degeneration

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INTERMEDIATE FILAMENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL MIGRATION; ELECTROPHYSIOLOGY; GENE INACTIVATION; GLIA; GLIOSIS; MOUSE; MUELLER CELL; NERVE FUNCTION; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RETINA; UPREGULATION; VISUAL ACUITY; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; ENERGY METABOLISM; METABOLISM; MOUSE MUTANT; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENERGY METABOLISM; GLIOSIS; MICE; MICE, KNOCKOUT; NERVE DEGENERATION; NEUROGLIA; NEURONS; RETINA;

EID: 80053584285     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-98     Document Type: Article

References (62)

1. Eddleston M, Mucke L. Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience 1993, 54(1):15-36. 10.1016/0306-4522(93)90380-X, 8515840.
2. Reier PJ. Gliosis following CNS injury: The anatomy of astrocyte scars and their influences on axonal elongation. 1986, Orlando: Academic Press.
3. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997, 20(12):570-577. 10.1016/S0166-2236(97)01139-9, 9416670.
4. Sarthy V, Ripps H. The retinal Müller cell: structure and function. 2001, New York: Kluwer Academic/Plenum Publishers.
5. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999, 23(2):297-308. 10.1016/S0896-6273(00)80781-3, 10399936.
6. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004, 24(9):2143-2155. 10.1523/JNEUROSCI.3547-03.2004, 14999065.
7. Gomi H, Yokoyama T, Fujimoto K, Ikeda T, Katoh A, Itoh T, Itohara S. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 1995, 14(1):29-41. 10.1016/0896-6273(95)90238-4, 7826639.
8. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Stahlberg A, Aprico K, Larsson K, et al. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2008, 28(3):468-481. 10.1038/sj.jcbfm.9600546, 17726492.
9. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996, 17(4):607-615. 10.1016/S0896-6273(00)80194-4, 8893019.
10. Otani N, Nawashiro H, Fukui S, Ooigawa H, Ohsumi A, Toyooka T, Shima K, Gomi H, Brenner M. Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice. J Clin Neurosci 2006, 13(9):934-938. 10.1016/j.jocn.2005.10.018, 17085299.
11. Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ 2007, 14(7):1324-1335. 10.1038/sj.cdd.4402144, 17431421.
12. Marc RE, Jones BW, Watt CB, Vazquez-Chona F, Vaughan DK, Organisciak DT. Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis 2008, 14:782-806. 2375357, 18483561.
13. Croisier E, Graeber MB. Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol 2006, 112(5):517-530. 10.1007/s00401-006-0119-z, 16896905.
14. Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, Faden AI. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci USA 2005, 102(23):8333-8338. 10.1073/pnas.0500989102, 1149422, 15923260.
15. Lewis GP, Fisher SK. Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol 2003, 230:263-290.
16. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50(4):427-434. 10.1002/glia.20207, 15846805.
17. Menet V, Gimenez y Ribotta M, Chauvet N, Drian MJ, Lannoy J, Colucci-Guyon E, Privat A. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci 2001, 21(16):6147-6158.
18. Rudge JS, Silver J. Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 1990, 10(11):3594-3603.
19. DiLoreto D, Ison JR, Bowen GP, Cox C, del Cerro M. A functional analysis of the age-related degeneration in the Fischer 344 rat. Curr Eye Res 1995, 14(4):303-310. 10.3109/02713689509033530, 7606916.
20. DiLoreto DA, Martzen MR, del Cerro C, Coleman PD, del Cerro M. Muller cell changes precede photoreceptor cell degeneration in the age-related retinal degeneration of the Fischer 344 rat. Brain Res 1995, 698(1-2):1-14. 10.1016/0006-8993(95)00647-9, 8581466.
21. Marc RE, Murry RF, Fisher SK, Linberg KA, Lewis GP. Amino acid signatures in the detached cat retina. Invest Ophthalmol Vis Sci 1998, 39(9):1694-1702.
22. Byrnes KR, Faden AI. Role of cell cycle proteins in CNS injury. Neurochem Res 2007, 32(10):1799-1807. 10.1007/s11064-007-9312-2, 17404835.
23. Crockett DP, Burshteyn M, Garcia C, Muggironi M, Casaccia-Bonnefil P. Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein p27Kip-1. Glia 2005, 49(2):301-308. 10.1002/glia.20111, 15472992.
24. Dyer MA, Cepko CL. Control of Muller glial cell proliferation and activation following retinal injury. Nat Neurosci 2000, 3(9):873-880. 10.1038/78774, 10966617.
25. Koguchi K, Nakatsuji Y, Nakayama K, Sakoda S. Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27(Kip1). Glia 2002, 37(2):93-104. 10.1002/glia.10017, 11754208.
26. Levine EM, Close J, Fero M, Ostrovsky A, Reh TA. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev Biol 2000, 219(2):299-314. 10.1006/dbio.2000.9622, 10694424.
27. Shen A, Liu Y, Zhao J, Qin J, Shi S, Chen M, Gao S, Xiao F, Lu Q, Cheng C. Temporal-spatial expressions of p27kip1 and its phosphorylation on Serine-10 after acute spinal cord injury in adult rat: Implications for post-traumatic glial proliferation. Neurochem Int 2008, 52(6):1266-1275. 10.1016/j.neuint.2008.01.011, 18319192.
28. Lopez-Sanchez E, Frances-Munoz E, Chaques V, Sanchez-Benavent ML, Menezo JL. Optic nerve alterations in P27(Kip1) knockout mice. Eur J Ophthalmol 2007, 17(3):377-382.
29. Cunningham JJ, Levine EM, Zindy F, Goloubeva O, Roussel MF, Smeyne RJ. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit. Mol Cell Neurosci 2002, 19(3):359-374. 10.1006/mcne.2001.1090, 11906209.
30. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008, 14(2):159-169. 10.1016/j.devcel.2008.01.013, 18267085.
31. Frank CL, Tsai LH. Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity. Neuron 2009, 62(3):312-326. 10.1016/j.neuron.2009.03.029, 2757047, 19447088.
32. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85(5):707-720. 10.1016/S0092-8674(00)81237-4, 8646779.
33. Tokita-Ishikawa Y, Wakusawa R, Abe T. Evaluation of Retinal Degeneration in P27KIP1 Null Mouse. Adv Exp Med Biol 2010, 664:467-471. 10.1007/978-1-4419-1399-9_53, 20238048.
34. Yoshida K, Kase S, Nakayama K, Nagahama H, Harada T, Ikeda H, Harada C, Imaki J, Ohgami K, Shiratori K, et al. Distribution of p27(KIP1), cyclin D1, and proliferating cell nuclear antigen after retinal detachment. Graefes Arch Clin Exp Ophthalmol 2004, 242(5):437-441. 10.1007/s00417-004-0861-7, 15029501.
35. Chien WM, Rabin S, Macias E, Miliani de Marval PL, Garrison K, Orthel J, Rodriguez-Puebla M, Fero ML. Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1. Proc Natl Acad Sci USA 2006, 103(11):4122-4127. 10.1073/pnas.0509514103, 1449657, 16537495.
36. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 2002, 244(2):305-318. 10.1006/dbio.2002.0597, 11944939.
37. Nayfield SG, Gorin MB. Tamoxifen-associated eye disease. A review. J Clin Oncol 1996, 14(3):1018-1026.
38. Slezak M, Goritz C, Niemiec A, Frisen J, Chambon P, Metzger D, Pfrieger FW. Transgenic mice for conditional gene manipulation in astroglial cells. Glia 2007, 55(15):1565-1576. 10.1002/glia.20570, 17823970.
39. Ekstrom P, Sanyal S, Narfstrom K, Chader GJ, van Veen T. Accumulation of glial fibrillary acidic protein in Muller radial glia during retinal degeneration. Invest Ophthalmol Vis Sci 1988, 29(9):1363-1371.
40. Shaw G, Weber K. The structure and development of the rat retina: an immunofluorescence microscopical study using antibodies specific for intermediate filament proteins. Eur J Cell Biol 1983, 30(2):219-232.
41. D'Ambrosio R. The role of glial membrane ion channels in seizures and epileptogenesis. Pharmacol Ther 2004, 103(2):95-108. 10.1016/j.pharmthera.2004.05.004, 15369678.
42. Marc RE, Murry RF, Basinger SF. Pattern recognition of amino acid signatures in retinal neurons. J Neurosci 1995, 15(7 Pt 2):5106-5129.
43. Winkler BS, Kapousta-Bruneau N, Arnold MJ, Green DG. Effects of inhibiting glutamine synthetase and blocking glutamate uptake on b-wave generation in the isolated rat retina. Vis Neurosci 1999, 16(2):345-353. 10.1017/S095252389916214X, 1885536, 10367968.
44. Kofuji P, Ceelen P, Zahs KR, Surbeck LW, Lester HA, Newman EA. Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina. J Neurosci 2000, 20(15):5733-5740. 2410027, 10908613.
45. Witkovsky P, Dudek FE, Ripps H. Slow PIII component of the carp electroretinogram. J Gen Physiol 1975, 65(2):119-134. 10.1085/jgp.65.2.119, 2214870, 1117278.
46. Pinto LH, Invergo B, Shimomura K, Takahashi JS, Troy JB. Interpretation of the mouse electroretinogram. Doc Ophthalmol 2007, 115(3):127-136. 10.1007/s10633-007-9064-y, 17636411.
47. Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci 2004, 45(12):4611-4616. 10.1167/iovs.04-0541, 15557474.
48. Close JL, Liu J, Gumuscu B, Reh TA. Epidermal growth factor receptor expression regulates proliferation in the postnatal rat retina. Glia 2006, 54(2):94-104. 10.1002/glia.20361, 16710850.
49. Ooto S, Akagi T, Kageyama R, Akita J, Mandai M, Honda Y, Takahashi M. Potential for neural regeneration after neurotoxic injury in the adult mammalian retina. Proc Natl Acad Sci USA 2004, 101(37):13654-13659. 10.1073/pnas.0402129101, 518808, 15353594.
50. Messing A, Brenner M. GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 2003, 43(1):87-90. 10.1002/glia.10219, 12761871.
51. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 2005, 11(5):400-407. 10.1177/1073858405278321, 16151042.
52. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006, 12(7):829-834. 10.1038/nm1425, 16783372.
53. Vazquez-Chona F, Song BK, Geisert EE. Temporal changes in gene expression after injury in the rat retina. Invest Ophthalmol Vis Sci 2004, 45(8):2737-2746. 10.1167/iovs.03-1047, 2821791, 15277499.
54. Zhang Y, Barres BA. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr Opin Neurobiol 2010, 20(5):588-594. 10.1016/j.conb.2010.06.005, 20655735.
55. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 1996, 93(13):6361-6366. 10.1073/pnas.93.13.6361, 39027, 8692820.
56. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007, 82:95-111.
57. Kinouchi R, Takeda M, Yang L, Wilhelmsson U, Lundkvist A, Pekny M, Chen DF. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat Neurosci 2003, 6(8):863-868. 10.1038/nn1088, 12845328.
58. Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE, Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol 1998, 152(2):391-398. 1857948, 9466565.
59. Quinlan RA, Brenner M, Goldman JE, Messing A. GFAP and its role in Alexander disease. Exp Cell Res 2007, 313(10):2077-2087. 10.1016/j.yexcr.2007.04.004, 2702672, 17498694.
60. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009, 32(12):638-647. 10.1016/j.tins.2009.08.002, 2787735, 19782411.
61. Vazquez-Chona FR, Clark AM, Levine EM. Rlbp1 promoter drives robust Muller glial GFP expression in transgenic mice. Invest Ophthalmol Vis Sci 2009, 50(8):3996-4003. 10.1167/iovs.08-3189, 19324864.
62. Marc RE, Jones BW. Molecular phenotyping of retinal ganglion cells. J Neurosci 2002, 22(2):413-427.